Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 47 min ago
Peer-reviewedCC BYCells

ADAMTS3 Promotes Hepatocellular Carcinoma Cell Growth and Migration Through TGF-β:TGFBR2 Signaling

10 affiliations
  1. 1College of Optical and Electronic Technology, China Jiliang University, Hangzhou 310018, China
  2. 2Key Laboratory of Quantum Precision Measurement, College of Physics, Zhejiang University of Technology, Hangzhou 310018, China
  3. 3Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310018, China
  4. 4College of Optical Science and Engineering, Zhejiang University, Hangzhou 310027, China
  5. 5Ultrafast Nanoscience Group, Department of Physics, Umeå University, Linnaeus väg 24, 901 87 Umeå, Sweden
  6. 6Umeå Centre for Microbial Research, Umeå University, Linnaeus väg 24, 901 87 Umeå, Sweden
  7. 7Wallenberg Initiative Materials Science for Sustainability, Department of Physics, Umeå University, Linnaeus väg 24, 901 87 Umeå, Sweden
  8. 8Optoelectronic Department, Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy
  9. 9Dipartimento di Scienze e Metodi dell’Ingegneria, Università degli Studi di Modena e Reggio Emilia, Viale Amendola 2, 14122 Reggio Emilia, Italy
  10. 10Experimental Research Center, Zhejiang Cancer Hospital, Hangzhou 310022, China

Abstract

Early diagnosis of hepatocellular carcinoma (HCC) still represents a significant challenge, particularly in the context of etiological shift toward obesity and non-viral liver disease-associated HCC. Through intersection-based analysis of independent transcriptomic datasets comprising healthy controls, individuals with obesity or NAFLD, and HCC patients with viral or non-viral etiologies, we prioritized ADAMTS3, a secreted protein, for further investigation of its functional and mechanistic relevance to HCC. ADAMTS3 was upregulated in HCC and demonstrated transcriptomic discrimination between HCC and non-HCC populations. Notably, in the validation cohort, ADAMTS3 retained discriminative capacity in clinically defined alpha-fetoprotein-negative HCC patients. Functionally, ADAMTS3 knockdown impaired cell proliferation, clonogenicity, and migration, while inducing apoptosis and cell-cycle arrest. Reintroduction of ADAMTS3 partially rescued these cellular effects. Mechanistically, ADAMTS3 promotes HCC cell growth and migration through TGF-β:TGFBR2 signaling. ADAMTS3 knockdown increased extracellular TGF-β and downstream SMAD phosphorylation. Neutralization of extracellular TGF-β alleviated growth inhibition caused by ADAMTS3 knockdown. Consistently, TGFBR2 knockdown partially restored the cell growth and migration suppressed by ADAMTS3 knockdown. We also developed a DNA origami-based SERS aptasensor targeting ADAMTS3, achieving highly sensitive detection of ADAMTS3 down to 10−12 M with strong quantitative capability (R2 = 0.914). Together, our findings support a role for ADAMTS3 in promoting HCC cell growth and migration and provide a basis for further investigation of its relevance to HCC biomarker development. The DNA origami-based SERS aptasensor provides a sensitive analytical approach for future studies of circulating or serum ADAMTS3.

Related

  1. ITGB1 Contributes to Matrix Stiffness–Induced Lipid Raft Organization and Promotes Hepatocellular Carcinoma Cell Migration
    Xu Zhang, Xinyu Liu, Yan Liu +1
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Cell biologyCrossref
  2. SPP1 promotes anoikis resistance and metastatic phenotypes in hepatocellular carcinoma through PI3K-sensitive signaling
    Xinyue Zhang, Honglong Wei, Reguang Pan +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossrefEurope PMCPMC
  3. H3K18 lactylation promotes Treg/Th17 imbalance via PTPRM-STAT3 axis in hepatocellular carcinoma
    Jianwei Yi, Zhonghuo Chen, Hengchang Zhu +9
    iSciencePeer-reviewedCC BY-NC 4.0Full textImmunologyOncologyCell PressCrossrefEurope PMC
  4. Disruption of p-AKT/ERβ-Mediated Midkine Signaling Promotes the Antimetastatic Effects of Timosaponin AIII in Nasopharyngeal Carcinoma Cells
    Chu-Che Lee, Yong-Syuan Chen, Shun-Fa Yang +3
    CellsPeer-reviewedCC BY 4.0Cell biologyCrossref
  5. GTSE1 promotes esophageal squamous cell carcinoma stemness via the Hippo signaling pathway.
    Yujie Xie, Dongmei Lai, Hao Hu +4
    Cellular oncology (Dordrecht, Netherlands)Peer-reviewedCC BY-NC-NDFull textCell biologyEurope PMCPMC
BibTeX
@article{wang2026adamts3,
  title = {{ADAMTS3 Promotes Hepatocellular Carcinoma Cell Growth and Migration Through TGF-β:TGFBR2 Signaling}},
  author = {Chen Wang and Huaizhou Jin and Qijie Zhang and Yanqiu Zou and Yaosen Wang and Nicolò Maccaferri and Ali Douaki and Jianguo Feng and Denis Garoli and Shangzhong Jin},
  journal = {Cells},
  year = {2026},
  month = sep,
  doi = {10.3390/cells15191784},
  url = {https://europepmc.org/article/PMC/PMC13664179},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - ADAMTS3 Promotes Hepatocellular Carcinoma Cell Growth and Migration Through TGF-β:TGFBR2 Signaling
AU  - Chen Wang
AU  - Huaizhou Jin
AU  - Qijie Zhang
AU  - Yanqiu Zou
AU  - Yaosen Wang
AU  - Nicolò Maccaferri
AU  - Ali Douaki
AU  - Jianguo Feng
AU  - Denis Garoli
AU  - Shangzhong Jin
PY  - 2026
DA  - 2026/09/30
JO  - Cells
DO  - 10.3390/cells15191784
UR  - https://europepmc.org/article/PMC/PMC13664179
AB  - Early diagnosis of hepatocellular carcinoma (HCC) still represents a significant challenge, particularly in the context of etiological shift toward obesity and non-viral liver disease-associated HCC. Through intersection-based analysis of independent transcriptomic datasets comprising healthy controls, individuals with obesity or NAFLD, and HCC patients with viral or non-viral etiologies, we prioritized ADAMTS3, a secreted protein, for further investigation of its functional and mechanistic relevance to HCC. ADAMTS3 was upregulated in HCC and demonstrated transcriptomic discrimination between HCC and non-HCC populations. Notably, in the validation cohort, ADAMTS3 retained discriminative capacity in clinically defined alpha-fetoprotein-negative HCC patients. Functionally, ADAMTS3 knockdown impaired cell proliferation, clonogenicity, and migration, while inducing apoptosis and cell-cycle arrest. Reintroduction of ADAMTS3 partially rescued these cellular effects. Mechanistically, ADAMTS3 promotes HCC cell growth and migration through TGF-β:TGFBR2 signaling. ADAMTS3 knockdown increased extracellular TGF-β and downstream SMAD phosphorylation. Neutralization of extracellular TGF-β alleviated growth inhibition caused by ADAMTS3 knockdown. Consistently, TGFBR2 knockdown partially restored the cell growth and migration suppressed by ADAMTS3 knockdown. We also developed a DNA origami-based SERS aptasensor targeting ADAMTS3, achieving highly sensitive detection of ADAMTS3 down to 10−12 M with strong quantitative capability (R2 = 0.914). Together, our findings support a role for ADAMTS3 in promoting HCC cell growth and migration and provide a basis for further investigation of its relevance to HCC biomarker development. The DNA origami-based SERS aptasensor provides a sensitive analytical approach for future studies of circulating or serum ADAMTS3.
SN  - 2073-4409
ER  -